Evogene Ltd
NASDAQ:EVGN
Evogene Ltd
Inventory
Evogene Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Evogene Ltd
NASDAQ:EVGN
|
Inventory
$2.1m
|
CAGR 3-Years
119%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Inventory
$85.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Inventory
$8.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Matricelf Ltd
TASE:MTLF
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evogene Ltd
Glance View
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
See Also
What is Evogene Ltd's Inventory?
Inventory
2.1m
USD
Based on the financial report for Sep 30, 2025, Evogene Ltd's Inventory amounts to 2.1m USD.
What is Evogene Ltd's Inventory growth rate?
Inventory CAGR 3Y
119%
Over the last year, the Inventory growth was 45%. The average annual Inventory growth rates for Evogene Ltd have been 119% over the past three years .
